Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares in GlaxoSmithKline plc purchased at a price of £10.28 per share on 16 April 2009, and Ordinary share ADRs in GlaxoSmithKline plc purchased at a price of $30.02 per ADR on 9 April 2009, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 9 April 2009.
|
Ordinary shares |
ADRs |
Mr A P Witty |
335.67 |
|
Mr J S Heslop |
0.01 |
|
Dr M M Slaoui |
97.64 |
|
Mrs C E Bruck Slaoui |
30.58 |
|
Mr S M Bicknell |
43.71 |
|
Mr J M Clarke |
204.19 |
|
Mr M Dunoyer |
126.42 |
|
Mr E J Gray |
126.87 |
|
Mr D Learmouth |
0.01 |
|
Mr W C Louv |
|
20.51 |
Mr D J Phelan |
|
188.35 |
Dr D Pulman |
|
108.95 |
Mr D S Redfern |
0.57 |
|
Ms C Thomas |
1.11 |
|
Mr J R Stéphenne |
353.75 |
|
The Company was advised of this information on 11 May 2009.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
11 May 2009